Placeholder Banner

Testimony of John F. Crowley, Executive Chairman of Amicus Therapeautics, to the House Committee on Energy and Commerce Subcommittee on Oversight and Investigations  for the hearing “How the IRA’s Price Setting Scheme Means Fewer Cures for Patients”

September 20, 2023

BIO Board Vice Chair and CEO of Amicus Therapeutics testified that the drug price controls in the Inflation Reduction Act harm drug research and development.

Download Full Comments Below
Discover More
BIO provided general comments and recommended edits Re: FDA-2023-D-3031
BIO submitted general comments and proposed changes to FDA (Docket No. FDA-2023-D-0026)
In these comments to FDA, BIO supports FDA’s efforts to improve future guidance related to Artificial Intelligence in Drug Manufacturing and outlines recommendations for FDA’s review and further consideration.